Control Bionics reports its strongest US revenue in years alongside Australia’s best quarter since 2022, propelled by new product launches and strategic investments.
Reckon Limited posted a modest revenue increase to $54.1 million for FY2024, yet net profit declined by 25.7%, reflecting margin pressures despite operational gains. The company also announced a strategic acquisition aimed at bolstering future growth.